Rubia, Hepolito E.

HRN: 25-69-32  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/31/2025
06/07/2025
IV
4.5g
Q8hr
CAPMR
Rejected 

 Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines